S'abonner

Implementation of pharmacist targeted discharge prescription review in an emergency department - 09/10/21

Doi : 10.1016/j.ajem.2021.04.054 
Emily Lineberry, PharmD, MS a, 1 , Elizabeth Rozycki, PharmD b , Trisha A. Jordan, PharmD, MS c, d , John Mellett, PharmD, MBA e , Andrew M. North, PharmD, MBA f,
a PGY1/PGY2 MS Health System Pharmacy Administration Resident, Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA 
b Specialty Practice Pharmacist - Emergency Medicine, Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA 
c Director, Patient Care Services, Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA 
d Assistant Professor, College of Pharmacy, The Ohio State University College of Pharmacy, Columbus, OH, USA 
e Clinical Applications Pharmacist, Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA 
f Specialty Practice Pharmacist - Emergency Medicine, Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 West 10th Avenue, 368 Doan Hall, Columbus, OH 43210, USA 

Corresponding author.

Abstract

Background/Purpose

Little data has been published regarding emergency medicine pharmacist (EMP) review of discharge prescriptions. An internal retrospective review of a limited sample size of emergency department (ED) discharge prescriptions demonstrated a 13.6% potential intervention rate by EMPs. With this information, it was postulated that EMPs could provide a valuable service via a process of targeted review of ED discharge prescriptions that would yield intervention rates higher than the internal audit. The aim of this project was therefore to develop a real-time notification system within the electronic health record (EHR) for targeted discharge prescription review, to establish an associated EMP workflow, and to evaluate the intervention rate achieved through targeted discharge prescription review.

Methods

This was a single-center, retrospective review of the implementation of a new pharmacist-driven clinical service over a 12 week period from February 19th, 2018 to May 14th, 2018. Criteria for prescription review were determined after an internal audit by the EMPs and included an assessment of established high-alert medications. Discharge prescriptions that met the inclusion criteria were filtered into a real-time work queue in the EHR for EMP review. When necessary, EMPs discussed recommendations with prescribers, or adjusted prescriptions according to institutional pharmacist privileges. Interventions were reviewed and categorized to assess rate of intervention and the types of medication-related problems (MRPs) identified.

Results

EMPs reviewed 378 discharge prescriptions and a total of 158 prescriptions were identified as having at least one MRP. Of these, 70 prescriptions were intervened upon thereby resulting in an 18.5% intervention rate. The most common interventions included a change in the dose/frequency, duration/refills of the medication, and patient education. The highest number of interventions were made for anticoagulant and antiinfective agents.

Conclusion

Utilization of a real-time notification system for prospective ED discharge prescription review is feasible. Using targeted criteria for review, pharmacists intervened on 18.5% of prescriptions reviewed. Prospective discharge prescription review by EMPs using a real-time notification system within the electronic health record identified opportunities for the pharmacist to ensure safe and optimal prescribing.

Le texte complet de cet article est disponible en PDF.

Highlights

ED discharge prescription review process created for emergency medicine pharmacists.
Impact of targeted prescription review demonstrated by an overall intervention rate of 18.5%.
Anticoagulant & anti-infective prescriptions exhibited highest intervention rates.
Interventions mainly comprised dose/frequency, duration/refills & patient education.
Pharmacist targeted ED discharge prescription review is a feasible clinical service.

Le texte complet de cet article est disponible en PDF.

Keywords : Emergency medicine, Pharmacists, Prescriptions, Patient discharge, Pharmacy service, hospital, Patient safety


Plan


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 48

P. 288-294 - octobre 2021 Retour au numéro
Article précédent Article précédent
  • Evaluation of fixed versus variable dosing of 4-factor prothrombin complex concentrate for emergent warfarin reversal
  • Zachary Stoecker, Brandon Van Amber, Casey Woster, Kurt Isenberger, Marissa Peterson, Paula Rupp, Ella Chrenka, David Dries
| Article suivant Article suivant
  • The effect of point-of-care ultrasound on length of stay in the emergency department in children with neck swelling
  • Mary Kate Claiborne, Carrie Ng, Kristen A. Breslin, James Chamberlain, Rosemary Thomas-Mohtat

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.